FTC settles with CVS drug price allegations
After a two-year investigation, the FTC has settled its deceptive pricing investigation with CVS Caremark Corp. The company will pay $5 million to settle charges that it misrepresented the prices of...To view the full article, register now.
Already a subscriber? Click here to view full article